Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
- Conditions
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2011-11-08
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 259
- Registration Number
- NCT00136851
- Locations
- ๐บ๐ธ
Novartis Pharmaceuticals, East Hanover, New Jersey, United States
Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2020-12-08
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 59
- Registration Number
- NCT00135005
- Locations
- ๐ฎ๐น
Novartis Investigative Site, Milano, MI, Italy
Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease
- Conditions
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2011-10-25
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 847
- Registration Number
- NCT00134979
Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2016-09-12
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 581
- Registration Number
- NCT00132808
- Locations
- ๐บ๐ธ
For information regarding facilities, please contact the Central Contact, E. Hanover, New Jersey, United States
Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
- Conditions
- First Posted Date
- 2005-08-17
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 127
- Registration Number
- NCT00131118
- Locations
- ๐บ๐ธ
UCLA Medical Center-Dept of Pediatric Nephrology, Los Angeles, California, United States
๐บ๐ธIntermountains Orthopedics, Boise, Idaho, United States
๐บ๐ธTexas Children's Hospital, Houston, Texas, United States
Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 476
- Registration Number
- NCT00124748
- Locations
- ๐บ๐ธ
Palm Beach Cancer Institute, West Palm Beach, Florida, United States
๐บ๐ธLSU Health Scine Center, Shreveport, Louisiana, United States
๐บ๐ธSt. Agnes Hospital, Baltimore, Maryland, United States
Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 1091
- Registration Number
- NCT00124709
- Locations
- ๐บ๐ธ
Children's Medical Group, Hopewell Junction, New York, United States
๐บ๐ธCentral Dermatology, St Louis, Missouri, United States
๐บ๐ธRx R & D, Metarie, Louisiana, United States
Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2005-07-27
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 85
- Registration Number
- NCT00124280
- Locations
- ๐บ๐ธ
Nevada Cancer Institute, Las Vegas, Nevada, United States
๐บ๐ธMD Anderson Cancer Center, Department of Thoracic /Head and Neck Medical Oncology, Houston, Texas, United States
Study of Oral AEE788 in Adults With Advanced Cancer
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 189
- Registration Number
- NCT00118456
- Locations
- ๐บ๐ธ
Yale Cancer Center, New Haven, Connecticut, United States
๐บ๐ธSarah Cannon Research Institute, Nashville, Tennessee, United States
๐บ๐ธNevada Cancer Institute, Las Vegas, Nevada, United States
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis
- Conditions
- Interventions
- First Posted Date
- 2005-07-08
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 720
- Registration Number
- NCT00117767
- Locations
- ๐บ๐ธ
Novartis Pharmaceuticals, East Hanover, New Jersey, United States